- Home
- TLRY vs AXGN Comparison
TLRY vs AXGN Comparison
Compare TLRY & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLRY
- AXGN
- Stock Information
- Founded
- TLRY N/A
- AXGN N/A
- Country
- TLRY Canada
- AXGN United States
- Employees
- TLRY N/A
- AXGN N/A
- Industry
- TLRY Medicinal Chemicals and Botanical Products
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TLRY Health Care
- AXGN Health Care
- Exchange
- TLRY Nasdaq
- AXGN Nasdaq
- Market Cap
- TLRY 871.2M
- AXGN 797.9M
- IPO Year
- TLRY 2018
- AXGN N/A
- Fundamental
- Price
- TLRY $0.95
- AXGN $18.00
- Analyst Decision
- TLRY Hold
- AXGN Strong Buy
- Analyst Count
- TLRY 3
- AXGN 3
- Target Price
- TLRY $1.88
- AXGN $18.33
- AVG Volume (30 Days)
- TLRY 51.2M
- AXGN 322.4K
- Earning Date
- TLRY 04-08-2025
- AXGN 02-25-2025
- Dividend Yield
- TLRY N/A
- AXGN N/A
- EPS Growth
- TLRY N/A
- AXGN N/A
- EPS
- TLRY N/A
- AXGN N/A
- Revenue
- TLRY $829,216,000.00
- AXGN $180,855,000.00
- Revenue This Year
- TLRY $15.63
- AXGN $19.41
- Revenue Next Year
- TLRY $5.63
- AXGN $13.08
- P/E Ratio
- TLRY N/A
- AXGN N/A
- Revenue Growth
- TLRY 18.38
- AXGN 18.79
- 52 Week Low
- TLRY $0.83
- AXGN $5.55
- 52 Week High
- TLRY $2.97
- AXGN $19.19
- Technical
- Relative Strength Index (RSI)
- TLRY 40.67
- AXGN 51.69
- Support Level
- TLRY $0.97
- AXGN $17.73
- Resistance Level
- TLRY $1.20
- AXGN $18.80
- Average True Range (ATR)
- TLRY 0.08
- AXGN 0.77
- MACD
- TLRY -0.00
- AXGN -0.08
- Stochastic Oscillator
- TLRY 33.72
- AXGN 52.96
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.